📰 Amgen News
Page 90 - Amgen News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Amgen. Real-time updates on events, politics, business and more.
April 3, 2024
Dumont & Blake Investment Advisors LLC reduced its stake in Amgen Inc. (NASDAQ:AMGN – Free Report) by 3.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,930 shares of the medical research company’s stock after selling 351 shares […]
April 3, 2024
Alvotechs 2024 plans include several product launches around the world through various partners, but the forthcoming introduction of SIMLANDI® in the U.S. is in a market that is truly in the
April 2, 2024
In his role as the new executive director of the Los Angeles chapter of statewide industry resource and advocacy group Biocom California, Dan Gober’s goal is to provide a boost to the region’s bioscience industry and its local microclusters.
April 2, 2024
The 101 Biotech Corridor has sprung up over the past quarter century in the region around biotech giant Amgen Inc.’s Thousand Oaks headquarters.
April 2, 2024
Perfromance Wealth Partners LLC cut its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 1.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 29,893 shares of the medical research company’s stock after selling 399 shares during the quarter. Amgen accounts for […]
April 2, 2024
The Biden administration said on Tuesday it has responded to offers from the manufacturers of 10 high-cost drugs selected for the U.S. Medicare programs first-ever pricing negotiations, but...
April 2, 2024
Acadia Pharmaceuticals Inc. today announced the appointment of Dr. Elizabeth H. Z. Thompson as Executive Vice President, Head of Research and Development. Dr. Thompson will lead research and...
April 2, 2024
TIAA Trust National Association increased its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 3.2% in the fourth quarter, HoldingsChannel reports. The firm owned 91,074 shares of the medical research company’s stock after buying an additional 2,807 shares during the quarter. TIAA Trust National Association’s holdings in Amgen were worth $26,231,000 at […]
April 2, 2024
TIAA Trust National Association increased its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 3.2% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 91,074 shares of the medical research company’s stock after buying an additional 2,807 shares during the quarter. TIAA Trust […]